Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Healthtrust
Citi
Cantor Fitzgerald
Johnson and Johnson

Generated: June 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,375,498

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,375,498 protect, and when does it expire?

Patent 9,375,498 protects NETSPOT and is included in one NDA.

This patent has twenty-four patent family members in eighteen countries.

Summary for Patent: 9,375,498
Title:Process for the preparation of complexes of .sup.68Ga
Abstract: A process for the preparation of complexes containing .sup.68Ga wherein a buffer formic acid/formate in the presence of compounds capable to sequester metal cations is used in the complexion reaction.
Inventor(s): Fugazza; Lorenza (San Fiorano, IT), Filannino; Maria Azzurra (Bertinoro, IT), Mariani; Maurizio Franco (Ivrea, IT)
Assignee: Advanced Accelerator Applications S.A. (Saint Genis Pouilly, FR)
Application Number:14/237,728
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 9,375,498
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process; Device;

Drugs Protected by US Patent 9,375,498

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,375,498

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyFI2011A0180Aug 12, 2011
PCT Information
PCT FiledAugust 10, 2012PCT Application Number:PCT/EP2012/065659
PCT Publication Date:February 21, 2013PCT Publication Number: WO2013/024013

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKesson
AstraZeneca
Fish and Richardson
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.